L-FABP関連文献
このコーナーでは、L-FABP関連の論文を、慢性腎臓病（CKD）、急性腎障害（AKI）、Toxicology、Pharmacologyに分類し、紹介いたします。
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（文献リストの赤色の数字）を入力の上、ご連絡ください。
文献カテゴリー
慢性腎臓病（CKD） 【新着】
- 203Clinical utility of tubular markers in kidney disease: a narrative review. J Lab Precis Med.2022
doi: 10.21037/jlpm-22-24JLPM - 200Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis. Front Med (Lausanne).2022
doi: 10.3389/fmed.2022.914587PubMed - 199Effects of dietary phosphorus concentration and phosphate salt form on renal tubule function in unilateral nephrectomized rats . Nutr Health.2022
doi: 10.1177/02601060221122223PubMed - 196Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study . Int J Nephrol.2022
doi: 10.1155/2022/2718810PubMed - 190Biomarkers for the early prediction ofcontrast-induced nephropathy after percutaneous coronary intervention in adults: A systematic review andmeta-analysis. Angiology.2022
doi: 10.1177/00033197211039921.PubMed
急性腎障害（AKI） 【新着】
- 204Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study). Philipp J Intern Med. 2022PJIM
- 203Clinical utility of tubular markers in kidney disease: a narrative review. J Lab Precis Med.2022
doi: 10.21037/jlpm-22-24JLPM - 202Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation. Clin Case Rep. 2022
doi: 10.1002/ccr3.6531PubMed - 198Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure. Heart Vessels. 2022
doi: 10.1007/s00380-022-02174-0PubMed - 195Early biomarkers for kidney injury inheat-related illness patients: a prospective observational study at Japanese Self-Defense Force FujiHospital. Nephrol Dial Transplant. 2022
doi: 10.1093/ndt/gfac166.PubMed - 194Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury. JAppl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021.PubMed - 193Urinary Biomarkers Can Predict Weaning From Acute DialysisTherapy in Critically Ill Patients. Arch Pathol Lab Med. 2022
doi:10.5858/arpa.2021-0411-OA.PubMed
薬剤性腎障害（Toxicology） 【新着】
- 201Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
doi: 10.5455/OVJ.2022.v12.i6.12 PubMed - 188Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol.2022
doi: 10.1186/s12882-022-02760-4. PubMed - 184Clinical Utility of a Biomarker to Detect Contrast-Induced AcuteKidney Injury during Percutaneous Cardiovascular Procedures. Cardiorenal Med.2022
doi: 10.1159/000520820. PubMed - 167Changing trends in lipid profile and biomarkers of renalfunction and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofoviralafenamide: a prospective observational study. AIDS Res Ther.2021
doi:10.1186/s12981-021-00354-y.PubMed - 153 Early changes in tubular dysfunction markers and phosphorusmetabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleosideanalog therapy for chronic hepatitis B patients. Hepatol Res.2020
doi:10.1111/hepr.13451. PubMed
薬理学（Pharmacology） 【新着】
- 182 Tubular Injury Causing Protracted GlycosuriaFollowing Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in theDevelopment of Protracted Hypoglycemia and Ketoacidosis. Tohoku J ExpMed.2021
doi: 10.1620/tjem.255.291. PubMed - 179Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition onBiomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized ControlledTrial. J Diabetes Res.2021
doi: 10.1155/2021/7382620.PubMed - 138Effect of linagliptin on oxidative stress markers in patientswith type 2 diabetes: a pilot study. Diabetol Int.2018
PubMed
運動（Exercise） 【新着】
- 197The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function . Physiol Rep. 2022
doi: 10.14814/phy2.15420.PubMed - 194Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury. JAppl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021.PubMed - 181Wearing a face mask during controlled-intensity exercise is nota risk factor for exertional heatstroke: A pilot study. Acute MedSurg.2021
doi: 10.1002/ams2.712.PubMed - 178Exercise Ameliorates Diabetic Kidney Disease in Type 2 DiabeticFatty Rats. Antioxidants (Basel).2021
doi: 10.3390/antiox10111754.PubMed - 148 Effects of exercise on residual renal function in patientsundergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial.
PubMed
新型コロナウイルス感染症（COVID-19） 【新着】
- 204Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study). Philipp J Intern Med. 2022PJIM
- J48 COVID－19と高血圧症・腎疾患 The Lipid33(1) 2022
- 192 Urine sediment findings were milder inpatients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renalinjuries. Int J Infect Dis. 2022
doi: 10.1016/j.ijid.2022.02.024. PubMed - 191Direct hemoperfusion using a polymyxinB-immobilized polystyrene column for COVID-19. J Clin Apher. 2021
doi:10.1002/jca.21861. PubMed - 187Metformin use in patients hospitalized withCOVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinicaloutcomes. J Thromb Thrombolysis. 2022
doi: 10.1007/s11239-022-02631-7. PubMed - 172First Experience Addressing the PrognosticUtility of Novel Urinary Biomarkers in Patients With COVID-19. Open ForumInfect Dis. 2021
doi: 10.1093/ofid/ofab274. PubMed - 171COVID-19-induced acute renal tubular injuryassociated with elevation of serum inflammatory cytokine. Clin Exp Nephrol.2021
doi: 10.1007/s10157-021-02101-z. PubMed - 155Evaluation of Coronavirus Disease 2019Severity Using Urine Biomarkers. Crit Care Explor. 2020
doi:10.1097/CCE.0000000000000170. PubMed
日本語総説 【新着】
- J48 COVID－19と高血圧症・腎疾患
- J47 【CKD 患者における抗がん薬治療】がん薬物療法前のAKIリスク評価とAKIバイオマーカー腎と透析93(3) 2022
- J46 慢性腎臓病の重症化予防に向けた運動の役割
- J45 習慣的な運動による老化関連疾患の予防
- J44 SGLT2 阻害薬ルセオグリフロジンの腎機能障害合併2 型糖尿病患者に対する有用性の検討 診療と新薬55, 2018
ガイドラインなど
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（下記リストの最初の数字）を入力の上、ご連絡ください。
